Recent advances in computational antimicrobial peptide discovery through big data, modeling, and artificial intelligence and their interplay in ushering the next golden era of drug development
Tope Abraham Ibisanmi, Xiaotao Jiang, Mark Willcox, Naresh Kumar

TL;DR
This paper explores how big data, modeling, and AI are transforming the discovery of antimicrobial peptides to combat antibiotic resistance.
Contribution
The paper unifies computational strategies for antimicrobial peptide discovery, highlighting their synergies and limitations.
Findings
Computational methods enable efficient in silico evaluation of peptide-target interactions and membrane disruption.
AI techniques predict and design novel antimicrobial peptides from genomic data with high accuracy.
Integration of molecular simulations and AI offers deeper insights into AMP mechanisms and accelerates discovery.
Abstract
The accelerating antimicrobial resistance (AMR) crisis continues to render more and more conventional antibiotics ineffective. Antimicrobial peptides (AMPs) are promising alternatives to traditional antibiotics due to their broad-spectrum activity, diverse mechanisms of action, and lower propensity for resistance. Traditional discovery approaches face limitations arising from the vast sequence space and the challenge of balancing efficacy with low toxicity. Addressing these challenges is critical for developing next-generation antimicrobial agents, and computational methods are increasingly driving progress. Public repositories, and techniques such as molecular docking enable in silico evaluation of peptide target interactions, identifying candidates with strong binding potential. Molecular dynamics (MD) simulations offer deeper insights into how AMPs disrupt membranes, form pores, or…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAntimicrobial Peptides and Activities · vaccines and immunoinformatics approaches · Microbial Natural Products and Biosynthesis
